contact us
subTop OurFunding

logo I2start

Development of clinician innovations towards MedTech Startups

SMART1    adminLoginLogo    EnterpriseSG 

Aim

I2Start program is a streamlined funding pathway which brings together three successful grant schemes: SMART Innovation Grant, NHIC Innovation to Develop (I2D) and ENTERPRISE SINGAPORE Startup SG Tech, in a manner to support company formation around medical technology innovations.

An I2Start application must clearly illustrate the technical feasibility of the technology, a defined go-to-market strategy, and demonstrate the potential for translation to a point where the technology would be attractive for a start-up company formation.

 

Eligibility

The team must consist of one Clinical Principal Investigator and one Technical Principal Investigator from Singapore public-funded institutions. The team should have a strong intention to start-up a company.

The Clinical PI must hold a primary appointment in a public healthcare institution or academic medical school in Singapore and be salaried by the institution.

The Technical PI must be employed by public-funded institution in Singapore (e.g. NUS, NTU, SUTD, SIT, SIM, SMU, A*STAR Institutions, Polytechnics, CREATE Institutions, SGH, DUKE-NUS, NUH and etc.). The Technical PI must have relevant scientific/technical background and possess necessary experience to co-direct the project being supported by the grant.

For any queries concerning eligibility, please contact the joint I2Start Grant Secretariat at This email address is being protected from spambots. You need JavaScript enabled to view it..

 

Funding criteria

Funding is considered if the application satisfies the following criteria:

  • Strong intellectual property position

  • Demonstrated preliminary proof of-concept data in in-vitro and/or in vivo research/laboratory models (TRL 3* and above)

  • Detailed technical and clinical development plan leading to a start-up, highlighting project scope, milestones and budget for each phase

  • Clear and achievable commercial plan outlining the unmet healthcare need, the proposed start-up structure and competitive landscape

* Definition: Technology Readiness Level 3 - Initial proof-of-concept demonstrated

 

The project should preferably fall under one of the following areas:

  • Clinical diagnostics

  • Medical device and products

  • Digital health

  • Life science tools

 

Please note that I2Start funding program does not support the following:

  • incremental or predictable next step in the improvement of existing technology

  • a simple combination of current technologies in a new format

  • setting up of manufacturing lines

  • drugs and biologics discovery/development

 

Funding Process

funding quantum i2s1a

All I2Start grant applications will be jointly evaluated by the 3 funding agencies.

Successful applicants will be awarded SMART Innovation Grant^ under Phase 1, alongside a Letter of Intent from NHIC.

Upon meeting the approved Phase 1 milestones, the project will transit into Phase 2, where it will be funded under NHIC I2D grant^. In parallel, ENTERPRISE SINGAPORE will provide a Letter of Intent to support the continuation of the project through the formation of a startup company.

Upon meeting the approved Phase 2 milestones and the required requisites**, the project will transit into Phase 3, whereby the startup company will be supported under Startup SG Tech POC/POV grant^. (To find out more general information about the ENTERPRISE SINGAPORE Startup SG Tech grant, please visit Startup SG Tech).

 

** Requisites:
(1) Incorporate a company (start-up) with key members hired full-time with at least 30% local shareholding, and
(2) License the IPs developed at SMART/ NHIC phase (Licensing agreement)

^ Individual grant terms apply

 

Funding Quantum and Duration

Phase 1: SMART Innovation Grant funding quantum is capped at S$250,000 (no indirect costs) awarded to the host institution. The SMART Innovation Grant funding support is up to 1 year.

Phase 2: NHIC I2D funding quantum is capped at S$250,000 (inclusive of max. 20% indirect costs) awarded to the host institution. The NHIC I2D funding support is up to 1 year.

Phase 3: ENTERPRISE SINGAPORE Startup SG Tech (SSG Tech) funding is capped at $250,000 for Proof-of-Concept (POC) projects and $500,000 for Proof-of-Value (POV) projects, awarded to startups incorporated in Singapore with at least 30% local shareholding. The SSG Tech funding support is up to 1 year for POC projects and 2 years for POV projects. To maintain financial discipline, startups would be required to increase its paid-up capital to 10% and 20% of the grant amount for POC and POV respectively.

 

Terms and Conditions

For the Terms and Conditions governing NHIC grants, please see Terms and Conditions.

For the Terms and Conditions governing ENTERPRISE SINGAPORE’s SSG Tech grants, please refer to eligibility criteria under http://www.startupsg.net/startupsg-tech/.

 

Grant Call

Letter of Intent is open throughout the year.

 

Submission details

The Letter of Intent must be submitted by Lead PI to the I2Start Grant Secretariat at This email address is being protected from spambots. You need JavaScript enabled to view it..

Applicants are required to include the project scope, milestones and budget for all the 3 grant phases through a single submission using the Letter of Intent template.

Shortlisted applicants will be invited to submit a formal grant application through the respective research office.

 

 

targetGroup_clinicianInnovators
targetGroup_ResearchAdministrator
targetGroup_IndustryPartner
targetGroup_Investor